Australis Capital Inc
CNSX:AUSA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Australis Capital Inc
CNSX:AUSA
|
US |
|
Treace Medical Concepts Inc
NASDAQ:TMCI
|
US |
|
C
|
Can Fite Biopharma Ltd
TASE:CANF
|
IL |
|
Honest Company Inc
NASDAQ:HNST
|
US |
|
Wayfair Inc
NYSE:W
|
US |
|
C
|
Coincheck Group NV
NASDAQ:CNCK
|
NL |
|
G
|
Guangdong Huiyun Titanium Industry Co Ltd
SZSE:300891
|
CN |
|
V
|
Visco Vision Inc
TWSE:6782
|
TW |
|
Horseshoe Metals Ltd
ASX:HOR
|
AU |
|
ABC India Ltd
BSE:520123
|
IN |
|
Austco Healthcare Ltd
ASX:AHC
|
AU |
|
Linius Technologies Ltd
ASX:LNU
|
AU |
|
Transense Technologies PLC
LSE:TRT
|
UK |
|
S
|
Sangshin Electronics Co Ltd
KOSDAQ:263810
|
KR |
|
Alvopetro Energy Ltd
XTSX:ALV
|
CA |
|
Brooks Macdonald Group PLC
LSE:BRK
|
UK |
Balance Sheet
Balance Sheet Decomposition
Australis Capital Inc
Australis Capital Inc
Balance Sheet
Australis Capital Inc
| Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
0
|
0
|
6
|
8
|
4
|
|
| Cash |
0
|
0
|
6
|
8
|
4
|
|
| Short-Term Investments |
0
|
0
|
0
|
1
|
13
|
|
| Total Receivables |
2
|
3
|
3
|
2
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
2
|
|
| Other Receivables |
0
|
0
|
3
|
2
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
22
|
13
|
5
|
|
| Total Current Assets |
2
|
3
|
31
|
24
|
24
|
|
| PP&E Net |
0
|
0
|
0
|
6
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
6
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
3
|
15
|
14
|
|
| Goodwill |
0
|
0
|
1
|
1
|
15
|
|
| Note Receivable |
0
|
0
|
6
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
17
|
18
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
7
|
0
|
22
|
|
| Other Assets |
0
|
0
|
1
|
1
|
15
|
|
| Total Assets |
2
N/A
|
3
+74%
|
65
+2 061%
|
64
-2%
|
82
+29%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
0
|
1
|
2
|
6
|
|
| Short-Term Debt |
2
|
3
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
2
|
1
|
|
| Total Current Liabilities |
2
|
3
|
2
|
4
|
7
|
|
| Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
3
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
5
|
|
| Other Liabilities |
0
|
0
|
3
|
1
|
4
|
|
| Total Liabilities |
2
N/A
|
3
+72%
|
4
+38%
|
6
+36%
|
21
+256%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
56
|
75
|
105
|
|
| Retained Earnings |
0
|
0
|
4
|
17
|
32
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
11
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
0
N/A
|
0
-36%
|
61
N/A
|
58
-5%
|
61
+6%
|
|
| Total Liabilities & Equity |
2
N/A
|
3
+74%
|
65
+2 061%
|
64
-2%
|
82
+29%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
113
|
113
|
145
|
170
|
226
|
|